The thymus is continuously seeded by progenitors derived from hematopoietic stem cells, which reside in the BM. These progenitors migrate via the blood stream into the thymus, where they adopt a T cell fate, proliferate, and diff erentiate into mature functional T cells. This differentiation process is characterized by multiple developmental stages. The earliest thymic progenitors lack surface expression of CD4 and CD8 and are therefore referred to as doublenegative (DN) thymocytes. They subsequently up-regulate both CD4 and CD8 coreceptors (double positive [DP]) before undergoing positive and negative selection, and maturing to CD4 and CD8 single-positive (SP) thymocytes that emigrate to the periphery. Immature DN thymocytes can be subdivided into four subpopulations according to the surface expression of CD117, CD44, and CD25. The most immature thymocyte progenitors (DN1) express CD117 and CD44 and are negative for CD25, followed by the DN2 population, which upregulates CD25, and the DN3 cells, which downregulate CD117 and CD44 before generating DN4 thymocytes lacking expression of all three markers ( 1, 2 ).
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The thymus is continuously seeded by progenitors derived from hematopoietic stem cells, which reside in the BM. These progenitors migrate via the blood stream into the thymus, where they adopt a T cell fate, proliferate, and diff erentiate into mature functional T cells. This differentiation process is characterized by multiple developmental stages. The earliest thymic progenitors lack surface expression of CD4 and CD8 and are therefore referred to as doublenegative (DN) thymocytes. They subsequently up-regulate both CD4 and CD8 coreceptors (double positive [DP] ) before undergoing positive and negative selection, and maturing to CD4 and CD8 single-positive (SP) thymocytes that emigrate to the periphery. Immature DN thymocytes can be subdivided into four subpopulations according to the surface expression of CD117, CD44, and CD25. The most immature thymocyte progenitors (DN1) express CD117 and CD44 and are negative for CD25, followed by the DN2 population, which upregulates CD25, and the DN3 cells, which downregulate CD117 and CD44 before generating DN4 thymocytes lacking expression of all three markers ( 1, 2 ) .
Over the last decade, many reports highlighted the importance of the evolutionarily conserved Notch cascade for the lymphoid system ( 3 ) . Mammals possess 4 Notch receptors (N1 -4), which are activated by two classes of with DL1. Data obtained in vitro support this hypothesis, because overexpression of DL4 in stromal cells can also direct T lymphopoiesis ( 16, 17 ) . In addition, overexpression of DL4 in BM precursors transferred into ␥ -irradiated mice leads to ectopic T cell development in the BM as well as a severe defect in B cell development ( 17 -19 ) . Moreover, we recently described a hierarchy of Notch -Delta interactions showing that the avidity of DL4 to bind to immature thymocytes is much higher than that of DL1. DL4 binding is high from the DN1 to DN3 stages and declines in DN4 to become undetectable in subsequent DP and SP thymocytes. This binding pattern parallels the functional requirements of Notch signaling during thymocyte development ( 20, 21 ) , suggesting that DL4 might play an important role during T cell development within the thymus.
In this report, we explore the function of DL4 within the thymus using a conditional loss-of-function approach. Our data show that Foxn1-Cre -mediated inactivation of DL4 within the thymic epithelium leads to a complete block in T cell development accompanied by ectopic B cell development within the thymus, which phenocopies mice with inducible inactivation of N1 in BM progenitors. Thus, DL4 is essential for T cell fate specifi cation and thereby represents the physiological partner of N1 during this process.
RESULTS AND DISCUSSION
Because DL1-and DL4-expressing OP-9 stromal cells ( 10, 16, 17 ) or normal thymic stroma ( 22 ) can both support the complete development of mature functional T cells from BM precursors in vitro, it is conceivable that either or both of these proteins function as physiological ligands for the N1 receptor during thymic T cell lineage commitment. To gain further insight into the expression pattern of DL1 and DL4 in the thymus, we analyzed thymi of mice in which the lacZ gene was knocked into either the DL1 or DL4 locus ( 23, 24 ) . LacZ staining on thymic sections derived from DL1 lacZ/+ mice was only positive for rare endothelial cells within the thymus, whereas DL4 LacZ/+ mice exhibited a strong reticular expression pattern within the outer cortex (characteristic of epithelial cells) and a weaker more punctuated staining within the medulla of the thymus ( Fig. 1 A ) . This expression pattern was confi rmed at the protein level using novel mAbs generated against the extracellular domains of DL1 and DL4. The specifi city of the anti-DL1 and -DL4 mAbs was tested on DL1-and DL4-expressing OP-9 cells. Anti-DL1 mAbs bound specifically to DL1-but not to DL4-expressing OP-9 cells, whereas the anti-DL4 mAbs showed a reciprocal binding pattern ( Fig. 1 B ) . These results indicate that both mAbs specifi cally bind to the corresponding Notch ligands and that they do not exhibit any cross-reactivity. These mAbs were then used to stain cell preparations enriched for TECs and analyzed by fl ow cytometry. TECs were identifi ed as CD45 Ϫ PanCytokeratin (PanCyt) + ( 25 ) and were further subdivided into cortical TECs (cTECs) and medullary TECs (mTECs) based on BP1 expression ( 26 ) . Anti-DL1 mAbs did not stain cTECs or mTECs above background. In contrast anti-DL4 mAbs showed signifi cant staining transmembrane bound ligands named Jagged 1 and 2, and Delta-like (DL) 1, 3, and 4. Notch signaling is initiated upon ligand receptor interaction, which results in the proteolytic release of the Notch intracellular cytoplasmic domain (NICD) of Notch receptors. The liberated NICD translocates to the nucleus and binds to the transcription factor RBP-J (also known as CSL), thereby converting it from a transcriptional repressor into an activator. Mastermind-like proteins are required for Notch signaling, as they bind to the NICD -RBP-J complex and recruit additional coactivators.
Multiple genetic loss-and gain-of-function experiments show that signaling mediated through the N1 receptor plays an important role for T cell lineage commitment and maturation within the thymus. Inducible inactivation of N1 in BM progenitors results in a block in T cell development and ectopic B cell development in the thymus, suggesting that N1 instructs an early thymic progenitor to adopt a T cell fate ( 4, 5 ) . An identical phenotype is observed in mice in which the RBP-J gene was inactivated in BM progenitors ( 6 ) , strongly indicating that T cell specifi cation is mediated by N1 -RBP-J -dependent signaling. Interference with Notch signaling by transgenic expression of modulators (such as Fringe , Deltex , or Nrarp ) or dominant-negative forms of transcriptional coactivators ( mastermind-like 1 ) also blocks T cell development concomitant with B lymphopoiesis in the thymus (for review see reference 3 ). Reciprocal gain-of-function studies overexpressing NICD in BM progenitors result in ectopic T cell development at the expense of B cell development ( 3 ). Thus, both loss-and gain-of-function studies demonstrate that N1 is essential for T lineage commitment. In addition, N1 -RBP-J signaling promotes the diff erentiation of pro -T cells into pre -T cells within the thymus by controlling rearrangement of the TCR ␤ locus ( 7 ) through regulating chromatin accessibility ( 8 ) , thereby assuring the successful generation of a pre-TCR complex, which is essential for thymocyte development.
Although N1 is unequivocally the key Notch receptor involved in T lineage commitment and thymic T cell maturation in vivo, the ligands that could be the physiological partners of N1 in these processes are still a matter of debate. The thymic epithelial microenvironment expresses all Notch ligands (mainly assessed by RT-PCR), except DL3 , which is hardly found in this organ ( 9 -12 ) . However, both Jagged ligands can be excluded from playing an essential role, as Jagged2 Ϫ / Ϫ and, more recently, Jagged1 Ϫ / Ϫ mice have been shown to have normal T cell development ( 13, 14 ) , thus implicating DL1 and/or DL4 ligands. Historically, DL1 has been favored as the potential N1 ligand in T cell fate specifi cation, because DL1-expressing stromal cells can support the complete development of mature functional T cells from BM precursors in vitro ( 10 ) . Moreover, when BM progenitors are co-cultured on stromal cells overexpressing DL1, B cell development is blocked ( 15 ) . Surprisingly, in contrast with these promising data obtained in vitro, conditional inactivation of DL1 in thymocytes and/or thymic epithelial cells (TECs) does not inhibit T cell development ( 16 ) . This discrepancy may be caused by the in vivo presence of DL4, which shares a high degree of homology BRIEF DEFINITIVE REPORT mRNA expression of the DL1 -driven lacZ gene is confi ned to blood vessels within the thymus, whereas DL4 drives expression preferentially within the cortical epithelium. The dashed lines indicate cortical -medullary boundaries. Bars, 100 μ m. (B) Anti-DL1 and -DL4 antibodies specifi cally bind their corresponding ligands without exhibiting cross-reactivity; OP-9 -DL1 -EGFP (top) and OP-9 -DL4 -EGFP (bottom) were stained with isotype Ctrl (shaded), anti-DL1 (dashed line), or anti-DL4 antibodies (continuous line; dilution, 1:100). The analysis was performed on gated EGFP-positive cells, and representative histograms are shown. (C) Anti-DL1 and -DL4 antibody staining on TECs. Enriched TECs extracted from wild-type thymi were stained for BP1 (3C6), CD45, and isotype Ctrl, anti-DL1, or anti-DL4 antibodies, followed by intracellular staining for PanCyt (C11) and fl ow cytometric analysis. Total TECs were gated as PanCyt + CD45 Ϫ (top left), and cTECs and mTECs were further defi ned as BP1 + the DL4 lox/lox ( Ctrl ) mice to knock-in mice expressing the Cre recombinase under the control of the Foxn1 gene ( 31 ), which is highly expressed in TECs, to generate DL4 lox/lox & Foxn1-Cre ( DL4 ⌬ Foxn1 ) mice ( Fig. 2 A ) . Staining of DL4 ⌬ Foxn1 TECs with anti-DL4 and -DL1 mAbs confi rmed the complete loss of DL4 protein in the gene-targeted mice compared with Ctrl animals ( Fig. 2 B ) . Interestingly, DL1 expression on TECs derived from DL4 ⌬ Foxn1 mice was not detectable, indicating that there is no functional compensation by DL1 as a consequence of loss of DL4 ( Fig. 2 B ) .
Side-by-side analysis of littermate thymi derived from Ctrl and DL4 ⌬ Foxn1 mice revealed a 14-fold decrease in absolute thymocyte numbers in DL4 ⌬ Foxn1 compared with Ctrl mice ( Fig. 3 A ) . Flow cytometric analysis of CD4 and CD8 expression on thymocytes derived from DL4 ⌬ Foxn1 mice shows nearly complete loss ( < 1%) of the CD4SP, the CD8SP, and the DP thymocyte subsets, whereas all of the major subsets are present in the expected frequency in Ctrl mice. DL4 ⌬ Foxn1 -derived thymi were almost exclusively populated with cells falling into the DN gate ( Fig. 3 A ) . In absolute numbers, DP, CD4SP, and CD8SP subsets were reduced by 180 -3,000-fold in DL4 ⌬ Foxn1 mice, whereas DN cells were slightly increased (twofold). Whether the small residual population of T lineage cells in the thymus of DL4 ⌬ Foxn1 mice results from a failure to of TECs, with brighter staining for cortical-(BP1 + ) versus medullary-(BP1 Ϫ ) derived populations ( Fig. 1 C ) . Analysis of thymocyte subpopulations for the expression of DL1 and DL4 with these mAbs was negative ( Fig. 1 D ) . These expression data are in general agreement with previous studies ( 18, 27, 28 ) , with the notable exception of one report in which TECs were broadly stained by a commercial polyclonal antibody against DL1 ( 12 ) . The specifi city of this polyclonal reagent has already been challenged by others ( 29 ) . In conclusion, the thymic expression pattern of DL1 and DL4 revealed by our novel mAbs confi rms the results obtained with the lacZ knock-in mice, strongly suggesting that DL4 might be the physiological ligand expressed by TECs that interacts with N1-expressing T cell precursors to specify the T cell lineage.
Studying the role of DL4 in hematopoiesis and, more specifi cally, during T lineage commitment by a conventional loss-of-function approach is hampered by the fact that DL4 gene-targeted mice are embryonic lethal ( 24, 30 ) . We therefore generated conditional gene-targeted mice for DL4 . These mice carry loxP sites fl anking the fi rst three coding exons of the DL4 gene ( DL4 lox/lox ). Because the gene expression and antibody studies suggested that DL4 expression in TECs might be critical for T cell lineage commitment, we crossed 
BRIEF DEFINITIVE REPORT mice 2 wk after N1 inactivation and compared them with BM B cells.
A small number of thymic B cells are present in Ctrl mice, and the majority have a mature IgM + B220 + phenotype. In contrast, a much larger population of B cells was found in DL4 ⌬ Foxn1 and N1 ⌬ Mx mice, and these B cells express heterogeneous levels of IgM and B220. Moreover, DL4 ⌬ Foxn1 and N1 ⌬ Mx B cells also express CD93 and BP1, which are typical markers for immature B cells, normally only present in the BM ( Fig. 4 A ) . All B220 + IgM Ϫ cells within the thymi of DL4 ⌬ Foxn1 and N1 ⌬ Mx mice were CD19 + , confi rming that these are indeed immature B cells (unpublished data). In absolute numbers, immature thymic B cells were increased 340-and 30-fold over Ctrl values in DL4 ⌬ Foxn1 and N1 ⌬ Mx mice, respectively ( Fig. 4 B ) . In conclusion, the immature B cell phenotype observed in the thymi of N1 ⌬ Mx mice is largely recapitulated in DL4 ⌬ Foxn1 mice, strongly suggesting that DL4 is the natural ligand for N1 during thymic T cell lineage commitment.
delete DL4 effi ciently in a subset of TECs (which stain below the threshold of detection with our anti-DL4 mAb) or, alternatively, represents a minor pathway of DL4-independent (and hence, presumably Notch-independent) T cell development remains to be investigated.
Further analysis of the DN thymic compartment of DL4 ⌬ Foxn1 mice for CD44 and CD25 expression reveals the presence of only CD44 + CD25 Ϫ DN1 cells, whereas all immature thymocyte subsets (DN1 -4) were present in normal numbers in Ctrl animals ( Fig. 3 B ) . Thus, the thymic phenotype of DL4 ⌬ Foxn1 mice is very similar to the one previously published for Notch1 lox/loxMx-Cre ( N1 ⌬ Mx ) mice ( 4, 5 ) . In the case of N1 ⌬ Mx mice, accumulating DN1 cells in the thymus were found to be ectopically developing B cells ( 4, 5 ) . Similarly, essentially all CD44 + CD25 Ϫ DN cells in DL4 ⌬ Foxn1 mice expressed B220, whereas only a small fraction of DN1 cells in Ctrl thymi were B220 + ( Fig. 3 C ) . To examine this phenotypic similarity in greater detail, we studied side-by-side B cells within the thymi of 2-wk-old Ctrl, DL4 ⌬ Foxn1 , and N1 ⌬ Mx effi ciently expand in the absence of competition, as all necessary cytokines and growth factors are abundantly present in the neonatal thymus.
Although Foxn1-Cre expression within the thymus should be restricted to TECs ( 31 ) and wild-type thymocytes do not stain detectably with anti-DL4 mAbs ( Fig. 1 D ) , it remains formally possible that rare DL4-expressing hematopoietic cells might be involved in T cell lineage commitment in the thymus. In this scenario, loss of DL4 expression on these cells could theoretically contribute to the generation of immature B cells in the DL4 ⌬ Foxn1 thymus. To exclude this possibility, we generated DL4 lox/loxMx-Cre ( DL4 ⌬ Mx ) mice to inducibly inactivate DL4 in BM progenitors. Because the Mx-Cre transgene is also active to some extent in TECs ( 16 ), BM from DL4 ⌬ Mx or Ctrl mice (both CD45.2 + ) was transplanted into CD45.1 + wild-type hosts to critically evaluate whether DL4 ⌬ Mx hematopoietic cells could contribute to the phenotype. Ctrl and DL4 ⌬ Mx BM chimeras were analyzed 8 wk after transplantation. The reconstitution effi ciency of CD45.2 + cells for Although DL4 ⌬ Foxn1 and N1 ⌬ Mx mice exhibit qualitatively similar thymic phenotypes, it is clear that enhancement of immature B cell development ( Fig. 4 B ) is more pronounced in the DL4 ⌬ Foxn1 background. This quantitative diff erence between DL4 ⌬ Foxn1 and N1 ⌬ Mx mice most likely refl ects the consequence of inactivation of the fl oxed DL4 and N1 genes using two diff erent Cre systems. The Mx-Cre transgene inducibly inactivates fl oxed genes preferentially in hematopoietic cells in the BM ( 32 ) . Thus, postnatal inactivation of N1 will generate N1-defi cient BM progenitors that will migrate to the thymus and develop into B cells that will have to compete with residual thymocytes for the availability of thymic niches, growth factors, and cytokines. In contrast, constitutive Foxn1-Cre -mediated DL4 gene inactivation in TECs occurs already during embryogenesis ( 31 ) . Thus, the fi rst wave of incoming lymphoid progenitors will encounter an empty DL4-defi cient thymic epithelium. Although these precursors cannot be instructed toward the T cell lineage, they can develop into the B cell lineage and 
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both Ctrl and DL4 ⌬ Mx chimeras was > 95%. A portion of the BM cells of the corresponding BM chimeras was analyzed by Southern blot analysis to ensure that reconstitution was not caused by rare cells that might have escaped deletion of the DL4 locus ( Fig. 5 E ) . As expected, Ctrl and DL4 ⌬ Mx BM progenitors generated all major blood lineages in the BM and spleen (unpublished data). More importantly, all major mature and immature thymocyte subsets were generated normally from Ctrl and DL4 ⌬ Mx BM progenitors ( Fig. 5, A and B ) , and only very small numbers of immature B cells were found in the thymus ( Fig. 5, C and D ) . These data exclude a significant role for putative DL4-expressing hematopoietic cells in thymic T cell lineage commitment.
Collectively, we have shown that DL4 is expressed by TECs, whereas DL1 is not detectable. Moreover, DL4 ⌬ Foxn1 mice exhibit a loss of DL4 expression in TECs, which correlates with a complete block in T cell development and the accumulation of immature B cells within the thymus. DL4 defi ciency within hematopoietic progenitors seems not to contribute to this phenotype, as assessed by BM chimeras, suggesting that the loss of DL4 on TECs is causative. A similar accumulation of immature thymic B cells is found in mice in which the N1 receptor is inactivated in hematopoietic progenitors. Collectively, these data demonstrate that DL4 expression on TECs is essential for thymic T cell development. Furthermore, they strongly suggest that N1-expressing T cell progenitors only commit to the T cell lineage after entry into the thymus.
Although in vitro DL1 and DL4 are functionally redundant in their ability to promote T cell development from BM precursors when expressed on OP9 cells, in vivo DL1 and DL4 mediate nonredundant functions within the hematopoietic system by binding to specifi c Notch receptors. Our data demonstrate that DL4 and N1 constitute within the thymus a nonredundant ligand -receptor pair essential for T cell lineage commitment. Similarly, DL1 pairs with N2 in the spleen to specify marginal zone B cell development in a nonredundant manner ( 16, 33 ) . Diff erential expression of Notch ligands has also been reported to infl uence T helper cell diff erentiation in peripheral CD4 T cells ( 34 ) . Thus, all of these examples are consistent with the possibility that specifi city of Notch signaling within the hematopoietic system might be generally regulated by tissue-specifi c expression of Notch ligands.
MATERIALS AND METHODS
Mice: generation of DL4 gene-targeted fl oxed mice. We generated the conditional Dl4 loss-of-function mutant mice by fl anking the fi rst three exons of the DL4 allele with two loxP sites. Mouse DL4 genomic clones were isolated from a 129/Sv genomic library. One loxP site was inserted into the 5 Ј untranslated region in the XhoI restriction site, 75 bp downstream of the transcription initiation site. The other loxP site, together with the fl ipase recognition target (FRT) site -fl anked PGK-neomycin selection cassette, was inserted in the EcoRI restriction site of intron 3. Upon Cre-mediated recombination, the translation initiation site and the coding sequence for the fi rst 132 amino acids of the protein were removed, creating a null allele. Electroporation and selection of embryonic stem (ES) cells (R1) was performed using standard protocols. Homologous recombination of the targeted DL4 Rat mAbs were generated against the extracellular domains of DL1 and DL4. Details of the immunization and screening will be presented in a future paper (unpublished data). Purifi ed mAbs were biotinylated in our laboratory according to standard protocols and revealed with streptavidin-PE. Both mAbs were assayed for specifi city on OP-9 stromal cells engineered to express DL1 or DL4 combined with enhanced GFP (OP-9 -DL1 -EGFP or OP-9 -DL4 -EGFP; Fig. 1 B ) .
